Metastatic pattern of ovarian cancer delineated by tracing the evolution of mitochondrial DNA mutations.
Metastatic pattern of ovarian cancer delineated by tracing the evolution of mitochondrial DNA mutations.
复制标题
通过追踪线粒体DNA突变的演变描绘卵巢癌的转移模式
DOI:
10.1038/s12276-023-01011-2
复制
发表时间:
2023-07
影响因子:
12.8
通讯作者:
Xing, Jinliang
中科院分区:
文献类型:
--
作者:
Xu, Zhiyang;Zhou, Kaixiang;Wang, Zhenni;Liu, Yang;Wang, Xingguo;Gao, Tian;Xie, Fanfan;Yuan, Qing;Gu, Xiwen;Liu, Shujuan;Xing, Jinliang
Ovarian cancer (OC) is the most lethal gynecologic tumor and is characterized by a high rate of metastasis. Challenges in accurately delineating the metastatic pattern have greatly restricted the improvement of treatment in OC patients. An increasing number of studies have leveraged mitochondrial DNA (mtDNA) mutations as efficient lineage-tracing markers of tumor clonality. We applied multiregional sampling and high-depth mtDNA sequencing to determine the metastatic patterns in advanced-stage OC patients. Somatic mtDNA mutations were profiled from a total of 195 primary and 200 metastatic tumor tissue samples from 35 OC patients. Our results revealed remarkable sample-level and patient-level heterogeneity. In addition, distinct mtDNA mutational patterns were observed between primary and metastatic OC tissues. Further analysis identified the different mutational spectra between shared and private mutations among primary and metastatic OC tissues. Analysis of the clonality index calculated based on mtDNA mutations supported a monoclonal tumor origin in 14 of 16 patients with bilateral ovarian cancers. Notably, mtDNA-based spatial phylogenetic analysis revealed distinct patterns of OC metastasis, in which a linear metastatic pattern exhibited a low degree of mtDNA mutation heterogeneity and a short evolutionary distance, whereas a parallel metastatic pattern showed the opposite trend. Moreover, a mtDNA-based tumor evolutionary score (MTEs) related to different metastatic patterns was defined. Our data showed that patients with different MTESs responded differently to combined debulking surgery and chemotherapy. Finally, we observed that tumor-derived mtDNA mutations were more likely to be detected in ascitic fluid than in plasma samples. Our study presents an explicit view of the OC metastatic pattern, which sheds light on efficient treatment for OC patients. Analysis of mitochondrial DNA offers new insights into cancer spread (metastasis) that could lead to more accurate prognoses and inform selection of better treatment regimens. Mitochondria carry their own DNA, which accumulates mutations at a far higher rate than does chromosomal DNA. These mutations can be extremely useful for tracing cellular lineages. Researchers led by Jinliang Xing and Shujuan Liu at the Fourth Military Medical University in Xi’an, China, have shown that these changes can also provide insights on tumor progression. They analyzed samples from 35 patients with ovarian cancer, revealing distinct differences between the mutational profiles of primary ovarian tumors and metastatic growths. Metastases that differed especially strongly from primary tissue responded more poorly to treatment. Future mitochondrial analyses could yield a better understanding of metastatic spread and the treatment of aggressive cancers.
登录
查看更多内容
影响因子:
30.8
作者:
Blakely CM;Watkins TBK;Wu W;Gini B;Chabon JJ;McCoach CE;McGranahan N;Wilson GA;Birkbak NJ;Olivas VR;Rotow J;Maynard A;Wang V;Gubens MA;Banks KC;Lanman RB;Caulin AF;St John J;Cordero AR;Giannikopoulos P;Simmons AD;Mack PC;Gandara DR;Husain H;Doebele RC;Riess JW;Diehn M;Swanton C;Bivona TG
通讯作者:
Bivona TG
影响因子:
7.7
作者:
Ju YS;Alexandrov LB;Gerstung M;Martincorena I;Nik-Zainal S;Ramakrishna M;Davies HR;Papaemmanuil E;Gundem G;Shlien A;Bolli N;Behjati S;Tarpey PS;Nangalia J;Massie CE;Butler AP;Teague JW;Vassiliou GS;Green AR;Du MQ;Unnikrishnan A;Pimanda JE;Teh BT;Munshi N;Greaves M;Vyas P;El-Naggar AK;Santarius T;Collins VP;Grundy R;Taylor JA;Hayes DN;Malkin D;ICGC Breast Cancer Group;ICGC Chronic Myeloid Disorders Group;ICGC Prostate Cancer Group;Foster CS;Warren AY;Whitaker HC;Brewer D;Eeles R;Cooper C;Neal D;Visakorpi T;Isaacs WB;Bova GS;Flanagan AM;Futreal PA;Lynch AG;Chinnery PF;McDermott U;Stratton MR;Campbell PJ
通讯作者:
Campbell PJ
影响因子:
14.9
作者:
Mikhailova, Alina G.;Mikhailova, Alina A.;Ushakova, Kristina;Tretiakov, Evgeny O.;Iliushchenko, Dmitrii;Shamansky, Victor;Lobanova, Valeria;Kozenkov, Ivan;Efimenko, Bogdan;Yurchenko, Andrey A.;Kozenkova, Elena;Zdobnov, Evgeny M.;Makeev, Vsevolod;Yurov, Valerian;Tanaka, Masashi;Gostimskaya, Irina;Fleischmann, Zoe;Annis, Sofia;Franco, Melissa;Wasko, Kevin;Denisov, Stepan;Kunz, Wolfram S.;Knorre, Dmitry;Mazunin, Ilya;Nikolaev, Sergey;Fellay, Jacques;Reymond, Alexandre;Khrapko, Konstantin;Gunbin, Konstantin;Popadin, Konstantin
通讯作者:
Popadin, Konstantin
影响因子:
7.3
作者:
Bashashati, Ali;Ha, Gavin;Tone, Alicia;Ding, Jiarui;Prentice, Leah M.;Roth, Andrew;Rosner, Jamie;Shumansky, Karey;Kalloger, Steve;Senz, Janine;Yang, Winnie;McConechy, Melissa;Melnyk, Nataliya;Anglesio, Michael;Luk, Margaret T. Y.;Tse, Kane;Zeng, Thomas;Moore, Richard;Zhao, Yongjun;Marra, Marco A.;Gilks, Blake;Yip, Stephen;Huntsman, David G.;McAlpine, Jessica N.;Shah, Sohrab P.
通讯作者:
Shah, Sohrab P.
影响因子:
6.4
作者:
Khalique, Lalarukh;Ayhan, Ayse;Ramus, Susan J.
通讯作者:
Ramus, Susan J.